Presentation is loading. Please wait.

Presentation is loading. Please wait.

Identification of Individual Cancer-Specific Somatic Mutations for Neoantigen-Based Immunotherapy of Lung Cancer  Takahiro Karasaki, MD, Kazuhiro Nagayama,

Published byMarilyn Heath Modified over 6 years ago

Similar presentations

Presentation on theme: "Identification of Individual Cancer-Specific Somatic Mutations for Neoantigen-Based Immunotherapy of Lung Cancer  Takahiro Karasaki, MD, Kazuhiro Nagayama,"— Presentation transcript:

1 Identification of Individual Cancer-Specific Somatic Mutations for Neoantigen-Based Immunotherapy of Lung Cancer  Takahiro Karasaki, MD, Kazuhiro Nagayama, MD, PhD, Mitsuaki Kawashima, MD, Noriko Hiyama, MD, Tomonori Murayama, MD, Hideki Kuwano, MD, PhD, Jun-ichi Nitadori, MD, PhD, Masaki Anraku, MD, MSc, Masaaki Sato, MD, PhD, Manami Miyai, MSc, Akihiro Hosoi, PhD, Hirokazu Matsushita, MD, PhD, Shingo Kikugawa, PhD, Ryo Matoba, PhD, Osamu Ohara, PhD, Kazuhiro Kakimi, MD, PhD, Jun Nakajima, MD, PhD  Journal of Thoracic Oncology  Volume 11, Issue 3, Pages (March 2016) DOI: /j.jtho Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

2 Figure 1 Pipelines to output potential neoantigens. (A) Off-the-shelf pipeline using a shared missense mutation panel curated from established online databases. Peripheral blood is a required sample to be collected from the patient. (B) Personalized pipeline using data from whole-exome sequencing. Samples of the patient’s tumor and normal tissue for control (e.g., adjacent normal lung tissue or peripheral blood) are needed. In both pipelines, mutant peptides are filtered using epitope binding prediction tools to select the potential neoantigens.21–23 COSMIC, Catalogue of Somatic Mutations in Cancer; HLA, human leucocyte antigen. Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

3 Supplemental Figure 1 Venn diagram showing the number of potential neoantigens detectable by whole-exome sequencing and targeted sequencing. A total of 1875 potential neoantigens were detected by whole-exome sequencing in 15 patients with lung cancer. If the currently available targeted sequencing assay for detection of a driver mutation were used, 32 potential neoantigens (including four off-the-shelf potential neoantigens) at most might be identified. Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Identification of Individual Cancer-Specific Somatic Mutations for Neoantigen-Based Immunotherapy of Lung Cancer  Takahiro Karasaki, MD, Kazuhiro Nagayama,"

Similar presentations

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages 1862-1863.

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer  Takahiro Karasaki, MD, Kazuhiro Nagayama, MD, PhD, Hideki.

An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer  Takahiro Karasaki, MD, Kazuhiro Nagayama, MD, PhD, Hideki.
Socializing Individualized T-Cell Cancer Immunotherapy

Socializing Individualized T-Cell Cancer Immunotherapy
Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules  Jie Wang, PhD, Shilpa Shivakumar, MD, Kristi Barker,

Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules  Jie Wang, PhD, Shilpa Shivakumar, MD, Kristi Barker,
Overview of next-generation sequencing, neoantigen prediction, and functional T-cell analyses. Overview of next-generation sequencing, neoantigen prediction,

Overview of next-generation sequencing, neoantigen prediction, and functional T-cell analyses. Overview of next-generation sequencing, neoantigen prediction,
Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers 

Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers 
Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 

Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 
Adrian G. Sacher, MD, Kimberly M. Komatsubara, MD, Geoffrey R

Adrian G. Sacher, MD, Kimberly M. Komatsubara, MD, Geoffrey R
T790M EGFR Mutation Detection in Cerebrospinal Fluid and Response to Osimertinib in a Lung Cancer Patient with Meningeal Carcinomatosis  Hugo Gortais,

T790M EGFR Mutation Detection in Cerebrospinal Fluid and Response to Osimertinib in a Lung Cancer Patient with Meningeal Carcinomatosis  Hugo Gortais,
SC17.02 Lung Cancer in China: Challenges and Perspectives

SC17.02 Lung Cancer in China: Challenges and Perspectives
ALK FISH and IHC: You Cannot Have One without the Other

ALK FISH and IHC: You Cannot Have One without the Other
EGFR and KRAS Mutations in Triple-Mutated Lung Cancer

EGFR and KRAS Mutations in Triple-Mutated Lung Cancer
A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient  Jong Sik Lee, MD, Jae Young Hur, PhD,

A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient  Jong Sik Lee, MD, Jae Young Hur, PhD,
The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients  Lecia V. Sequist, MD, MPH, Sunitha Nagrath, PhD, Mehmet.

The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients  Lecia V. Sequist, MD, MPH, Sunitha Nagrath, PhD, Mehmet.
Applications of Immunogenomics to Cancer

Applications of Immunogenomics to Cancer
T790M EGFR Mutation Detection in Cerebrospinal Fluid and Response to Osimertinib in a Lung Cancer Patient with Meningeal Carcinomatosis  Hugo Gortais,

T790M EGFR Mutation Detection in Cerebrospinal Fluid and Response to Osimertinib in a Lung Cancer Patient with Meningeal Carcinomatosis  Hugo Gortais,
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer  Suzanne Jenkins, DPhil, James C-H.

Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer  Suzanne Jenkins, DPhil, James C-H.

Similar presentations

Ads by Google